Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 6Melanoma 6Colorectal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Neoplasms 3Head and Neck Neoplasms 3Colonic Neoplasms 3Uterine Cervical Dysplasia 2Skin Neoplasms 2Sarcoma, Kaposi 2Sarcoma 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Inflammatory Breast Neoplasms 2HIV Infections 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Unspecified Adult Solid Tumor, Protocol Specific 1Turcot syndrome 1Thrombocytosis 1

Interventions

obeticholic acid 1Specimen Handling 1Endoscopy, Gastrointestinal 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Attenuated familial adenomatous polyposis × Biopsy × Clear all
NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡